• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Clorox Company

    6/26/25 4:18:46 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary
    Get the next $CLX alert in real time by email
    11-K 1 clx4503001-11k.htm ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    ____________________

     

    FORM 11-K

     

    FOR ANNUAL REPORTS OF EMPLOYEE STOCK

    PURCHASE, SAVINGS AND SIMILAR PLANS

    PURSUANT TO SECTION 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    (Mark One):

     

    ☑       ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the fiscal year ended December 31, 2024

     

    OR

     

    ☐       TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from ___________________ to ____________________

     

    Commission file number 1-07151

     

    A.       Full title of the plan and the address of the plan, if different from that of the issuer named below:

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

     

    B.       Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

     

    The Clorox Company

    1221 Broadway

    Oakland, CA 94612-1888

     

     

     

    Report of Independent Registered Public Accounting Firm
    Financial Statements and Supplemental Information

     

    The Clorox Company Employee Retirement Investment Plan for Puerto Rico

     

    As of December 31, 2024 and 2023 and for the
    Plan year ended December 31, 2024

     

     

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

     

    Financial Statements and Supplemental Information

     

    As of December 31, 2024 and 2023

    and for the Plan Year ended December 31, 2024

     

    Contents

     

    Report of Independent Registered Public Accounting Firm 1
       
    Audited Financial Statements  
       
    Statements of Net Assets Available for Benefits 4
    Statement of Changes in Net Assets Available for Benefits 5
    Notes to Financial Statements 6
       
    Supplemental Information  
       
    Schedule H, Line 4i – Schedule of Assets (Held at End of Year) 14
       
    Exhibit 23.1 – Consent of Independent Registered Public Accounting Firm 17

     

     

    Report of Independent Registered Public Accounting Firm

     

    To the Plan Administrator and Participants of

    The Clorox Company Employee

    Retirement Investment Plan for Puerto Rico

     

    Opinion on the Financial Statements

     

    We have audited the financial statements of The Clorox Company Employee Retirement Investment Plan for Puerto Rico (the “Plan”), an employee benefit plan subject to the Employee Retirement Income Security Act of 1974 (ERISA), which comprise the statements of net assets available for benefits as of December 31, 2024 and 2023, and the related statement of changes in net assets available for benefits for the year ended December 31, 2024, and the related notes to the financial statements.

     

    In our opinion, the accompanying financial statements present fairly, in all material respects, the net assets available for benefits of The Clorox Company Employee Retirement Investment Plan for Puerto Rico as of December 31, 2024 and 2023, and the changes in its net assets available for benefits for the year ended December 31, 2024, in accordance with accounting principles generally accepted in the United States of America.

     

    Basis for Opinion

     

    We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of The Clorox Company Employee Retirement Investment Plan for Puerto Rico and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

     

    Responsibilities of Management for the Financial Statements

     

    Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

     

    In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about The Clorox Company Employee Retirement Investment Plan for Puerto Rico ability to continue as a going concern for the year ended December 31, 2024.

     

    Management is also responsible for maintaining a current plan instrument, including all plan amendments, administering the plan, and determining that the plan’s transactions that are presented and disclosed in the financial statements are in conformity with the plan’s provisions,

     

    1

     

    including maintaining sufficient records with respect to each of the participants, to determine the benefits due or which may become due to such participants.

     

    Auditor’s Responsibilities for the Audit of the Financial Statements

     

    Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users made on the basis of these financial statements.

     

    In performing an audit in accordance with GAAS, we:

     

    • Exercise professional judgment and maintain professional skepticism throughout the audit.

     

    • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks.

     

    Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

     

    • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of The Clorox Company Employee Retirement Investment Plan for Puerto Rico internal control. Accordingly, no such opinion is expressed.

     

    • Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

     

    • Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about The Clorox Company Employee Retirement Investment Plan for Puerto Rico’s ability to continue as a going concern for a reasonable period of time.

     

    We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

     

    2

     

    Other Matter—Supplemental Schedule Required by ERISA

     

    Our audits were conducted for the purpose of forming an opinion on the financial statements as a whole. The supplemental Schedule H, line 4(i) – Schedule of Assets (Held at End of Year) as of December 31, 2024 is presented for purposes of additional analysis and are not a required part of the financial statements but are supplementary information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under ERISA. Such information is the responsibility of management and was derived from and relates directly to the underlying accounting and other records used to prepare the financial statements. The information has been subjected to the auditing procedures applied in the audits of the financial statements and certain additional procedures, including comparing and reconciling such information directly to the underlying accounting and other records used to prepare the financial statements or to the financial statements themselves, and other additional procedures in accordance with GAAS.

     

    In forming our opinion on the supplemental schedules, we evaluated whether the supplemental schedules, including their form and content, are presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under ERISA.

     

    In our opinion, the information in the accompanying schedules is fairly stated, in all material respects, in relation to the financial statements as a whole, and the form and content are presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under ERISA.

     

    /s/ Moss Adams LLP

     

    Campbell, California

    June 26, 2025

     

    We have served as the Plan’s auditor since 2013.

     

    3

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

    Statements of Net Assets Available for Benefits

    As of December 31, 2024 and 2023

     

       December 31, 
       2024   2023 
             
    Assets          
    Investments, at fair value  $20,694,177   $18,153,438 
    Receivables:          
    Notes receivable from participants   446,374    336,503 
    Employers' contributions   241,264    273,729 
    Total receivables   687,638    610,232 
    Net assets available for benefits  $21,381,815   $18,763,670 

     

    See accompanying notes to the financial statements

     

    4

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

    Statement of Changes in Net Assets Available for Benefits

    For the Plan Year ended December 31, 2024

     

    Additions to (deductions from) net assets attributed to:     
    Investment and other income:     
    Interest income and dividends  $396,769 
    Net appreciation in fair value of investments   2,120,073 
    Total investment and other income   2,516,842 
          
    Contributions:     
    Participants   404,383 
    Employers   394,389 
    Total contributions   798,772 
          
    Benefits paid to participants   (673,455)
    Administrative expenses   (24,014)
    Total benefits paid and administrative expenses   (697,469)
          
    Net increase   2,618,145 
          
    Net assets available for benefits:     
    Beginning of year   18,763,670 
    End of year  $21,381,815 

     

    See accompanying notes to the financial statements

     

    5

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

     

    Notes to Financial Statements

     

    December 31, 2024

     

    1. Description of the Plan

     

    The following description of The Clorox Company Employee Retirement Investment Plan for Puerto Rico (“the Plan”) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

     

    General

     

    The Plan is a defined contribution plan covering most salaried and hourly production employees of Clorox Manufacturing Company of Puerto Rico, Inc. (the “Company”) and those affiliates of the Company that adopt the Plan for the benefit of their Puerto Rico resident employees (the “Companies”), except for (i) leased employees and (ii) non-resident aliens with no Puerto Rico source of income, unless such coverage is specified in the written agreement. Participants are eligible to participate on the first day of employment following completion of one hour of service with the Companies. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). The Employee Benefits Committee (the “Committee”) administers the Plan. Banco Popular de Puerto Rico serves as the Plan’s trustee. Vanguard Group, Inc. (“Vanguard”) serves as the Plan’s record-keeper and custodian.

     

    The Companies maintain a non-leveraged employee stock ownership plan (the “ESOP”). The ESOP is maintained as part of the Plan and is designed to invest primarily in the Company’s common stock. If elected, the participants can choose to (i) reinvest the dividends or (ii) receive the dividends in cash. No participant shall be permitted to direct more than 5% of the contributions to be made to the Plan on his or her behalf in the ESOP fund; and no participant shall be permitted to effect a transfer or exchange from another investment fund into the ESOP fund if the portion of the participant’s account invested in the ESOP fund would exceed 5% of his or her account balance immediately after such transfer or exchange.

     

    Contributions

     

    Participants may contribute up to 20% of their covered compensation, up to 10% on a pre-tax and after-tax basis, respectively, as defined in the Plan. Generally, covered/eligible compensation consists of regular pay plus most bonuses, overtime and vacation pay.

     

    Pre-tax contributions are subject to a $15,000 limit specified under the Puerto Rico Internal Revenue Code of 2011, as amended, (the “Code”).

     

    Newly eligible participants who do not make a salary deferral contribution election, or fail to elect to decline a deferral contribution, are automatically enrolled in the Plan at a 6% contribution rate.

     

    6

     

    Employees receive a dollar for dollar employer matching contribution up to a maximum of 4% of eligible compensation. Participants need to have completed one year of service to receive the match. Matching contributions are funded each pay period.

     

    Eligible participants also receive a non-elective employer contribution.  Participants must have completed one year of service and be an active employee at the end of the Plan year to be able to receive the non-elective employer contribution. The non-elective employer contribution is equal to 6% of eligible compensation during the plan year. The non-elective employer contribution is funded during the quarter subsequent to the Plan year end. See “Vesting” section for more information.

     

    Participants may also rollover amounts representing distributions from other qualified defined benefit or defined contribution plans.

     

    Investment Options

     

    Participants direct investment of their contributions and the Companies’ contributions into the various investment options offered by the Plan. The Plan offers investments in The Clorox Company’s common stock, mutual funds, common collective trust funds and a money market fund.

     

    Participant Accounts

     

    Each participant’s account is credited with the participant’s contribution and an allocation of: (a) Company contributions and (b) Plan earnings. Allocations are based on participant’s eligible compensation for the employer match and employer non-elective contributions and investment balance for investment earnings. At the discretion of the Committee, forfeited balances of terminated participants’ non-vested accounts may be used to pay Plan expenses, to reduce the Companies’ contributions to the Plan, or to restore forfeited accounts of previously terminated participants who subsequently resumed employment with the Companies.

     

    7

     

    Vesting

     

    Participants are always fully vested in their individual contributions, the Companies’ matching contributions, and actual earnings thereon.

     

    The non-elective employer contributions account will vest in accordance with the following schedule:

     

    Years of Service  Percentage
    1   0%
    2   20%
    3   40%
    4   66%
    5   100%

     

    Participants become immediately vested in the non-elective employer contribution upon reaching age 60 while employed by the Companies, at death, or upon termination of employment due to permanent disability.

     

    Payment of Benefits

     

    The Plan provides for lump-sum distributions of the vested value of a participant’s account upon death, permanent disability, or termination of employment. The Plan also provides for installment distributions in limited instances. Hardship withdrawals are permitted if certain criterion are met.

     

    Notes Receivable from Participants

     

    Participants may obtain up to two loans for a minimum of $1,000 each and a maximum amount equal to the lesser of $50,000 reduced by the highest outstanding loan balance in the previous 12 months, or 50% of the participant’s vested account balance. Loan terms range from 1 to 5 years, or up to 15 years if the proceeds are used for the purchase of a primary residence. The loans are secured by the balance of the participant’s account and bear interest at a fixed rate (prime plus 1%) determined at the time of the loan. Principal and accrued interest is repaid ratably through payroll deductions. Outstanding notes receivable at December 31, 2024 carry interest rates ranging from 4.25% to 9.50%.

     

    Plan Termination

     

    Although it has not expressed any intent to do so, the Companies have the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of a Plan termination, participants will become 100% vested in their accounts.

     

    8

     

    Administrative Expenses

     

    The Company pays all administrative expenses except for the quarterly recordkeeping fees, certain investment fees and loan fees, which are deducted from the affected participant’s account.

     

    Forfeitures

     

    The unallocated forfeitures related to non-vested accounts at December 31, 2024 and 2023 are $11,549 and $3,502, respectively. Subsequent to year end, the Companies used $3,686 and $4,914 of forfeitures to reduce the Companies’ non-elective employer contributions for the Plan years ended December 31, 2024 and 2023, respectively.

     

    2. Summary of Significant Accounting Policies

     

    Basis of Accounting

     

    The accompanying financial statements are prepared on the accrual basis of accounting in accordance with Accounting Principles Generally Accepted in the United States of America (U.S. GAAP”).

     

    The Plan’s financial statements were evaluated for subsequent events from the date after the financial statement date through June 26, 2025, the date the financial statements were available to be issued.

     

    Investment Valuation and Income Recognition

     

    The Plan’s investments are stated at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 5 for further discussion of fair value measurements.

     

    Purchases and sales of securities are recognized on a trade-date basis. Interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. The net appreciation in fair value of investments consists of both the realized gains and losses and unrealized appreciation and depreciation of those investments.

     

    Benefit Payments to Participants

     

    Benefit payments to participants are recognized upon payment.

     

    Use of Estimates

     

    The preparation of financial statements in conformity with U.S. GAAP requires the Plan’s management to make estimates that affect the amounts reported in the financial statements and accompanying footnotes. Actual results could differ from those estimates.

     

    9

     

    Notes Receivable from Participants

     

    Notes receivable from participants are measured at their unpaid principal balance plus any accrued but unpaid interest. Interest income is recorded on the accrual basis. Delinquent participant loans are reclassified as distributions based upon the terms of the Plan Document.

     

    Risk and Uncertainties

     

    The Plan provides for various investment options in common stock, mutual funds, common collective trust funds and a money market fund. Investment securities, in general, are exposed to various risks, such as interest rate, credit, and overall market volatility risk. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities could occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, the statement of changes in net assets available for benefits and participant account balances.

     

    3. Party-in-Interest Transactions

     

    Certain Plan assets are in investment funds managed by the custodian of the Plan’s assets; therefore, these transactions qualify as party-in-interest transactions under the provisions of ERISA for which a statutory exemption exists.

     

    In addition, a portion of the Plan's assets are participant directed investments in The Clorox Company common stock. As the Companies are subsidiaries of The Clorox Company, the Plan transactions involving The Clorox Company common stock qualify as party-in-interest transactions. During the Plan year ended December 31, 2024, the Plan purchased or received approximately $7,014 and sold or distributed approximately $15,907 of the Company’s common stock.

     

    4. Income Tax Status

     

    The Plan has received a determination letter from the Puerto Rico Treasury Department dated May 3, 2013, stating that the Plan meets the requirements of section 1081.01 (d) of the Code and that the trust established thereunder will be entitled to exemption from local income taxes. Subsequent to this determination by the Puerto Rico Treasury Department, the Plan was amended. The Plan’s management believes the Plan is being operated in compliance with applicable requirements of the Code and, therefore, believes that the Plan, as amended and restated, is qualified and the related trust is tax-exempt.

     

    U.S. GAAP requires Plan management to evaluate uncertain tax positions taken by the Plan. The financial statement effects of a tax position are recognized when the position meets certain recognition thresholds or measurement standards defined by U.S. GAAP. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that, as of December 31, 2024, there are no uncertain positions taken or expected to be taken. The Plan recognized no interest or

     

    10

     

    penalties related to uncertain tax positions. The Plan may be subjected to routine audits by the taxing jurisdictions; however, there are currently no audits in progress for any tax periods.

     

    5. Fair Value Measurements

     

    Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., an exit price). Fair value is determined based on a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. An asset or liability’s classification is based on the lowest level of input that is significant to the fair value measurement.

     

    Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

     

    Level 1 –Quoted market prices in active markets for identical assets or liabilities.

     

    Level 2 –Observable market-based inputs or unobservable inputs that are corroborated by market data.

     

    Level 3 –Unobservable inputs reflecting management’s own assumptions

     

    The following is a description of the valuation methodologies used for assets and liabilities measured at fair value:

     

    Mutual funds: Valued at quoted market prices of shares held by the Plan at year-end.

     

    Company’s common stock: Valued at the last reported sales price on the last business day of the Plan year.

     

    Common collective trust funds: Valued using the market approach at a net asset value per share (“NAV” as a practical expedient) determined by the portfolio’s sponsor based on the fair value of underlying investments held by the fund on the last business day of the Plan year. These are not classified in the fair value hierarchy table. The fair values are included in the table to allow reconciliation of the fair value hierarchy to the fair value of investments per the statements of net assets available for benefits.

     

    The stable value common collective trust fund measured at net asset value may impose, in its sole discretion, a prior notice period of up to 12 months for any plan initiated withdrawal of assets. Certain funds may also require that within 90 days from withdrawal, money from the funds cannot be invested directly into a competing fund. Certain funds retain the right to reject transactions where market timing activity is detected. Rejection can occur within 90 days, or for multiple infractions, rejection can be temporary or permanent. Generally, completing two ‘round trips’ within 60 days is considered market timing. A round trip consists of purchase or exchange if followed by or preceded by redemption or exchange out. Others retain discretion to limit the

     

    11

     

    maximum withdrawal as of any date to the greater of $2,000,000 or 5% of the value of the investment.

     

    The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

     

    The following table sets forth by level, within the fair value hierarchy, the Plan’s assets at fair value as of December 31, 2024 and 2023:

     

       Assets at Fair Value as of December 31, 2024 
       Level I   Level II   Total 
    Mutual funds  $11,007,824   $-   $11,007,824 
    The Clorox Company common stock   790,547    -    790,547 
    Total assets in the fair value hierarchy   11,798,371    -    11,798,371 
    Common collective trust funds measured at NAV, practical expedient             8,895,806 
    Investments at fair value            $20,694,177 
       Assets at Fair Value as of December 31, 2023 
       Level I   Level II   Total 
    Mutual funds  $9,859,136   $-   $9,859,136 
    The Clorox Company common stock   679,505    -    679,505 
    Total assets in the fair value hierarchy   10,538,641    -    10,538,641 
    Common collective trust funds measured at NAV, practical expedient             7,614,797 
    Investments at fair value            $18,153,438 

    12

     

    Supplemental Information

     

     

    The Clorox Company

    Employee Retirement Investment Plan for Puerto Rico

     

    EIN: 31-0595760 – Plan Number: 007

    Schedule H, Line 4(i) - Schedule of Assets (Held at End of Year)

    December 31, 2024

     

       (b) Identity of issue,
    (a) Borrower, Lessor, or Similar Party
      (c) Description
    of Investment
      (e) Current value 
               
    *  Vanguard Institutional Total International Stock Market Index Trust  Mutual fund  $1,506,123 
       Eaton Vance Atlanta Capital SMID Cap Fund  Mutual fund   849,041 
       Northern Global Sustainability Index Fund  Mutual fund   23,489 
    *  Vanguard Target Retirement 2025 Fund  Mutual fund   785,270 
    *  Vanguard Target Retirement 2030 Fund  Mutual fund   306,310 
    *  Vanguard Target Retirement 2035 Fund  Mutual fund   3,425,207 
    *  Vanguard Target Retirement 2040 Fund  Mutual fund   403,485 
    *  Vanguard Target Retirement 2045 Fund  Mutual fund   3,291,273 
    *  Vanguard Target Retirement 2050 Fund  Mutual fund   231,543 
    *  Vanguard Target Retirement 2055 Fund  Mutual fund   54,727 
    *  Vanguard Target Retirement 2065 Fund  Mutual fund   2,677 
    *  Vanguard Target Retirement Inc Fund  Mutual fund   128,679 
                
              11,007,824 
                
    *  Vanguard Institutional 500 Index Trust  Common collective trust fund   3,905,874 
    *  Vanguard Institutional Total Bond Market Index Trust  Common collective trust fund   1,703,284 
       State Street Small Mid Cap Trust  Common collective trust fund   1,377,519 
       J.P. Morgan Chase Bank US Active Core Equity Fund  Common collective trust fund   912,267 
       Galliard Stable Return Fund  Common collective trust fund   594,608 
       MFS International Equity Fund  Common collective trust fund   261,056 
       MetWest Total Return Bond Fund  Common collective trust fund   141,198 
              8,895,806 
                
    *  The Clorox Company Common Stock  Common stock   790,547 
                
    *  Participant Loans  Interest rates ranging from 4.25 to 9.50%   446,374 
                
       Total investments     $21,140,551 

    * Represents a party-in-interest to the Plan

    Note: Column (d) Cost is not presented as all investments are participant directed

     

    14

     

     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

      THE CLOROX COMPANY
      EMPLOYEE RETIREMENT INVESTMENT PLAN
    FOR PUERTO RICO
       
    Date:  June 26, 2025 /s/ Angela Hilt
      Angela Hilt
      Executive Vice President – Chief Legal and
      External Affairs Officer and Corporate Secretary

    15

     

    Index to Exhibits

    Exhibit No. Description
       
    23.1 Consent of Moss Adams LLP

    16

    Get the next $CLX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLX

    DatePrice TargetRatingAnalyst
    10/1/2025$118.00 → $112.00Underweight
    Barclays
    1/7/2025$157.00Underweight → Equal Weight
    Wells Fargo
    11/6/2024$155.00 → $170.00Sell → Hold
    TD Cowen
    10/1/2024$174.00 → $187.00Hold → Buy
    Jefferies
    7/23/2024$122.00Sell
    TD Cowen
    6/24/2024$130.00Underperform
    Exane BNP Paribas
    4/2/2024$170.00 → $165.00Buy → Neutral
    Citigroup
    3/26/2024$145.00Underperform → Hold
    Jefferies
    More analyst ratings

    $CLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays reiterated coverage on Clorox with a new price target

    Barclays reiterated coverage of Clorox with a rating of Underweight and set a new price target of $112.00 from $118.00 previously

    10/1/25 10:49:28 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Clorox from Underweight to Equal Weight and set a new price target of $157.00

    1/7/25 7:46:13 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox upgraded by TD Cowen with a new price target

    TD Cowen upgraded Clorox from Sell to Hold and set a new price target of $170.00 from $155.00 previously

    11/6/24 6:16:23 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clorox Announces November 3 Webcast of First-Quarter Fiscal Year 2026 Results

    OAKLAND, Calif., Oct. 13, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) will issue its first-quarter fiscal year 2026 results on November 3, 2025. Timing for the announcement will be as follows: 1:15 p.m. PT / 4:15 p.m. ET: Press release and prepared management remarks posted on the company's website2 p.m. PT / 5 p.m. ET: Live Q&A audio webcast for analysts with Chair and CEO Linda Rendle and Chief Financial Officer Luc BelletLinks to the webcast, press release and prepared remarks can be found at Clorox quarterly results. About The Clorox Company The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Cloro

    10/13/25 4:30:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Declares Regular Quarterly Dividend of $1.24 Per Share

    OAKLAND, Calif., Sept. 16, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared a quarterly dividend of $1.24 per share on the company's common stock. The dividend is payable November 6, 2025, to shareholders of record as of the close of business on October 22, 2025. Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases. About The Clorox Company The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® a

    9/16/25 8:00:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    CloroxPro Unveils New Screen+ Sanitizing Wipes, Designed to Safely Clean and Sanitize Sensitive Electronics

    First-of-its-kind Screen+ Sanitizing Wipes offer hi-tech hygiene for today's facilities and shared workspaces. OAKLAND, Calif., Sept. 3, 2025 /PRNewswire/ -- CloroxPro, the trusted makers of Clorox professional products, announced the launch of Clorox Screen+ Sanitizing Wipes today — a breakthrough product designed specifically for cleaning and sanitizing touchscreens, laptops, tablets, keyboards and other sensitive electronics. Screen+ Sanitizing Wipes are as advanced as the world we live in, safeguarding facilities by killing 99.9% of bacteria1 and removing fingerprints, dust and smudges without damaging delicate screens.2

    9/3/25 9:15:00 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    SEC Filings

    View All

    SEC Form DEFA14A filed by Clorox Company

    DEFA14A - CLOROX CO /DE/ (0000021076) (Filer)

    10/7/25 4:16:56 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form DEF 14A filed by Clorox Company

    DEF 14A - CLOROX CO /DE/ (0000021076) (Filer)

    10/7/25 4:16:34 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 10-K filed by Clorox Company

    10-K - CLOROX CO /DE/ (0000021076) (Filer)

    8/8/25 4:15:21 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP - CAO & Corp Controller Peck Laurene E was granted 1,418 shares and covered exercise/tax liability with 279 shares, increasing direct ownership by 19% to 6,992 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    10/7/25 5:11:12 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Chief Executive Officer Rendle Linda J was granted 43,370 shares and covered exercise/tax liability with 9,462 shares, increasing direct ownership by 20% to 201,990 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    10/7/25 5:11:14 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    EVP - Executive Chief of Staff Grier Stacey was granted 9,913 shares and covered exercise/tax liability with 1,032 shares, increasing direct ownership by 38% to 32,203 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    10/7/25 5:10:14 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Breber Pierre R bought $546,285 worth of shares (4,000 units at $136.57) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    5/9/25 4:25:25 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Leadership Updates

    Live Leadership Updates

    View All

    Clorox Announces Appointment of Julia Denman and Stephanie Plaines to its Board of Directors

    OAKLAND, Calif., May 18, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the appointment of Julia (Charter) Denman and Stephanie Plaines to its board of directors, bringing additional deep financial expertise and industry leadership experience. Denman, 51, brings nearly 30 years of leadership and financial experience in both the technology and consumer packaged goods sectors. As corporate vice president and head of internal audit, enterprise risk and compliance at Microsoft, she provides independent and objective assessments of the company's business strateg

    5/18/22 4:30:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Financials

    Live finance-specific insights

    View All

    Clorox Declares Regular Quarterly Dividend of $1.24 Per Share

    OAKLAND, Calif., Sept. 16, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared a quarterly dividend of $1.24 per share on the company's common stock. The dividend is payable November 6, 2025, to shareholders of record as of the close of business on October 22, 2025. Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases. About The Clorox Company The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® a

    9/16/25 8:00:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Reports Q4 and FY25 Results, Provides FY26 Outlook

    Delivers strong margin expansion and adjusted EPS growth for FY25 despite challenging environment in the second half of the fiscal year OAKLAND, Calif., July 31, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the fourth quarter and fiscal year 2025, which ended June 30, 2025. Fourth-Quarter Fiscal Year 2025 Summary The following is a summary of key fourth-quarter results, which reflect the temporary benefit from incremental shipments related to building retailer inventory in advance of the enterprise resource planning transition in the U.S. (incremental ERP shipments) and the impact from the prior divestiture of the Better Health Vitamins, Minerals and Supplem

    7/31/25 4:10:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Increases Quarterly Dividend to $1.24 Per Share

    OAKLAND, Calif., July 30, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared an increase to its quarterly dividend from $1.22 to $1.24 per share on the company's common stock. The dividend is payable August 29, 2025, to shareholders of record as of the close of business on August 13, 2025. Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases. About The Clorox Company The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liqu

    7/30/25 5:15:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/13/24 5:02:29 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/23 11:15:26 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/22 3:43:30 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary